Re (RMAX) Cash & Equivalents (2012 - 2026)

Re (RMAX) has 15 years of Cash & Equivalents data on file, last reported at $107.1 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $107.1 million, up 20.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $107.1 million (up 20.22% YoY), and the FY2025 annual result was $118.7 million, up 22.89% from the prior year.
• Cash & Equivalents declined to $107.1 million in Q1 2026 per RMAX's latest filing, from $118.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $118.7 million in Q4 2025 and troughed at $66.1 million in Q2 2024.
• A 5-year average of $98.5 million and a median of $96.8 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 31.72% in 2024, then soared 42.76% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $108.7 million in 2022, then decreased by 23.96% to $82.6 million in 2023, then climbed by 16.94% to $96.6 million in 2024, then gained by 22.89% to $118.7 million in 2025, then declined by 9.78% to $107.1 million in 2026.
• Business Quant data shows RMAX's Cash & Equivalents at $107.1 million in Q1 2026, $118.7 million in Q4 2025, and $107.5 million in Q3 2025.